pharmaceuticals for the treatment of diseases of neurodegeneration, neurogenesis, cardiometabolic diseases, fibrosis, energy expenditure, muscle wasting, cancers, and inflammation, all developed by a proprietary assay technology for assessing drug efficacy

'assay':25 'assess':28 'cancer':17 'cardiometabol':10 'develop':21 'diseas':6,11 'drug':29 'efficaci':30 'energi':13 'expenditur':14 'fibrosi':12 'inflamm':19 'muscl':15 'neurodegener':8 'neurogenesi':9 'pharmaceut':1 'proprietari':24 'technolog':26 'treatment':4 'wast':16

KINEMED

Owners

Goods & Services